Serum alkaline phosphatase and the risk of coronary heart disease, stroke and all-cause mortality: Tehran Lipid and Glucose Study

OBJECTIVES: To investigate the association of alkaline phosphatase (ALP) levels with the risk of the composite end point of cardiovascular disease (CVD), and all-cause mortality as well as each of them separately. DESIGN: Prospective cohort study. SETTING: Within the framework of the Tehran Lipid an...

Descripción completa

Detalles Bibliográficos
Autores principales: Kabootari, Maryam, Raee, Mohammad Reza, Akbarpour, Samaneh, Asgari, Samaneh, Azizi, Fereidoun, Hadaegh, Farzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254490/
https://www.ncbi.nlm.nih.gov/pubmed/30478120
http://dx.doi.org/10.1136/bmjopen-2018-023735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254490/
https://www.ncbi.nlm.nih.gov/pubmed/30478120
http://dx.doi.org/10.1136/bmjopen-2018-023735

Ejemplares similares